Yi Shou Cao

Yi Shou Cao (Herba Pterocephali) is the dried whole plant of Pterocephalus hookeri (C.B. Clarke) Hoeck, a perennial herbaceous plant in the family Caprifoliaceae (traditionally placed in Dipsacaceae). In the traditional TCM classification system, Yi Shou Cao is considered bitter in flavor with a cold nature. It enters the Liver and Spleen meridians, giving it a role in formulas that address toxic heat, wind-dampness bi syndrome, and inflammatory swellings.

Botanical description: Pterocephalus hookeri is a small perennial herb growing 5–30 cm tall. The plant has a short, thick rhizome with numerous fibrous roots. The basal leaves form a rosette, with spatulate to oblanceolate blades 3–10 cm long and 1–3 cm wide, entire or slightly toothed, covered with fine hairs. The flowering stem is erect and slender, bearing a single terminal spherical to ovoid flower head 1.5–3 cm in diameter. The small flowers are densely packed, with white to pale pinkish-purple corollas. The distinctive spherical flower heads give the plant its common name "winghead." The infructescence retains the persistent pappus-like bracts, giving the fruiting head a feathery appearance. The whole plant is harvested during the flowering period and dried in the shade.

Habitat and cultivation: P. hookeri is native to the high-altitude regions of the Himalayas and the Qinghai-Tibet Plateau. It grows at elevations of 3,000–5,000 meters in alpine meadows, grassy slopes, and rhododendron scrub. In China, it is primarily found in the provinces of Tibet (Xizang), Sichuan (particularly the western and northwestern highland areas), Qinghai, and Yunnan. The plant is also distributed in Nepal, Bhutan, and northern India. Due to its high-altitude habitat and slow growth, wild populations are relatively limited. The herb is primarily wild-harvested, and cultivation efforts are in the early stages. The harsh growing conditions of the alpine environment are believed to contribute to the plant's pharmacological potency in traditional medicine.

Quality markers: High-quality Yi Shou Cao should consist of the complete dried plant including roots, basal leaves, and flower heads. The material should have a grayish-green to yellowish-brown color, with intact flower heads that retain their characteristic spherical shape. The total iridoid glycoside content, particularly sweroside and loganin, is used as a quality indicator in modern pharmacognosy. The triterpenoid content, including ursolic acid and oleanolic acid, is also monitored. Material should be free of excessive soil, foreign matter, mold, or insect damage. Premium-grade material is characterized by its intact flower heads, green basal leaves, and high iridoid glycoside content.

In the traditional Chinese medicine theoretical framework, Yi Shou Cao is understood in terms of its effects on specific patterns of disharmony (zheng). Because Yi Shou Cao enters the Liver and Spleen meridians and has a bitter, cold quality, it is traditionally indicated for a range of patterns involving toxic heat, wind-dampness, and inflammatory swelling.

Clearing heat and detoxifying: Yi Shou Cao is considered a potent heat-clearing and detoxifying herb in TCM. In TCM theory, when toxic heat accumulates, the body may manifest as sore throat, skin eruptions, boils, carbuncles, and fever. Yi Shou Cao is traditionally used to clear heat toxins and reduce inflammation. It is often combined with Ban Lan Gen and Lian Qiao in formulas for toxic heat patterns. Its cold nature makes it particularly suitable for patterns of excess heat rather than deficiency heat. In Tibetan medicine, Yi Shou Cao is used for fever and inflammatory conditions, reflecting a cross-cultural recognition of its heat-clearing properties.

Dispelling wind and eliminating dampness: Yi Shou Cao is traditionally used to dispel wind and eliminate dampness, making it an important herb for wind-dampness bi syndrome. In TCM theory, when wind, dampness, and cold combine to obstruct the channels and collaterals, the body may manifest as joint pain, stiffness, swelling, and limited mobility. Yi Shou Cao is traditionally used to dispel these pathogenic factors and relieve bi syndrome. It is often combined with Du Huo and Qin Jiao in formulas for wind-dampness patterns. Its ability to address both heat and dampness makes it particularly suitable for damp-heat bi syndrome, where joint pain is accompanied by local heat and swelling.

Relieving pain: Yi Shou Cao is traditionally used for its analgesic properties, particularly for pain associated with inflammatory conditions and bi syndrome. It is indicated for joint pain, muscle pain, and pain associated with swellings and skin eruptions. Its bitter, cold nature is believed to help clear heat and reduce the inflammatory processes that contribute to pain. In folk practice, Yi Shou Cao is prepared as a decoction for systemic pain relief or applied topically as a poultice for localized inflammatory pain.

Reducing swelling: Yi Shou Cao is traditionally used to reduce swelling, both in the context of inflammatory swellings and traumatic injuries. In TCM theory, swellings may arise from toxic heat, blood stasis, or damp accumulation. Yi Shou Cao is believed to address the underlying heat and toxin while also reducing the visible swelling. It is used both internally and topically for boils, carbuncles, and traumatic swelling. The saponin constituents in Yi Shou Cao are believed to contribute to its swelling-reducing effects, though this is based on traditional use rather than confirmed clinical evidence.

Tibetan medicine context: Yi Shou Cao has a significant place in Tibetan traditional medicine, where it is used under a different name and theoretical framework. In Tibetan medicine, the plant is classified according to the three humors (rlung, mkhris-pa, bad-kan) and is used primarily for conditions involving excess heat and blood disorders. The incorporation of Yi Shou Cao into the Chinese Pharmacopoeia reflects the growing recognition of multi-ethnic medicinal traditions in modern Chinese medicine. The Tibetan use of this herb for fever and inflammation is consistent with its TCM classification as a heat-clearing herb, demonstrating the convergence of different medical traditions on similar therapeutic applications.

Classical literature references: Yi Shou Cao is not a major herb in the classical Han-era materia medica texts. Its use is primarily documented in Tibetan medical texts such as the Sibu Yidian (Four Medical Tantras) and in regional Chinese herbal texts from Sichuan and Tibet. The Crystal Pearl Materia Medica (Jingzhu Bencao), a Tibetan pharmacopoeia compiled in the 19th century, recorded the use of this herb for "clearing heat, detoxifying, and treating blood disorders." Modern compilations of Chinese folk medicine from the Sichuan and Tibetan regions describe its use for fever, sore throat, and inflammatory joint conditions.

Yi Shou Cao contains a range of bioactive compounds that have been the subject of pharmacological investigation. The following overview summarizes the major chemical constituents identified in the whole plant of Pterocephalus hookeri and what is currently known about them from published research.

Sweroside: Sweroside is a secoiridoid glycoside and one of the most characteristic and well-studied constituents of Yi Shou Cao. It has been investigated in pre-clinical research for its anti-inflammatory, hepatoprotective, and antioxidant properties. Sweroside has been shown to inhibit pro-inflammatory cytokine production in macrophage models and to protect against liver injury in animal models of hepatotoxicity. Its bitter taste is characteristic of iridoid glycosides and contributes to the traditional classification of Yi Shou Cao as a bitter herb. Most research on sweroside has been conducted on the isolated compound, and the clinical relevance for oral TCM use is not well established.

Loganin: Loganin is an iridoid glycoside found in Yi Shou Cao and other Caprifoliaceae plants. It has been studied for its neuroprotective, anti-inflammatory, and antioxidant properties. Pre-clinical research has investigated loganin's potential for protecting against neurodegeneration in animal models, modulating inflammatory responses, and reducing oxidative stress. Loganin is also a key constituent of Cornus officinalis (Shan Zhu Yu) and other TCM herbs, and its pharmacological profile has been the subject of considerable research interest. Its contribution to the overall effects of Yi Shou Cao is still being investigated.

Ursolic acid: Ursolic acid is a pentacyclic triterpenoid found in Yi Shou Cao and many other medicinal plants. It has been extensively studied for its anti-inflammatory, antioxidant, antimicrobial, and potential antitumor properties. Ursolic acid has been shown to inhibit multiple inflammatory signaling pathways, including NF-kappaB and COX-2, in pre-clinical models. Its presence in Yi Shou Cao may contribute to the herb's traditional anti-inflammatory and detoxifying effects. However, most research on ursolic acid has been conducted on the isolated compound, and its bioavailability and clinical effects when consumed as part of whole-herb preparations are not well characterized.

Oleanolic acid: Oleanolic acid is another pentacyclic triterpenoid found in Yi Shou Cao. It is structurally related to ursolic acid and shares many of its pharmacological properties, including anti-inflammatory, hepatoprotective, and antioxidant effects. Oleanolic acid has been investigated for its potential to protect against liver injury, modulate immune function, and reduce inflammation. In some pre-clinical studies, oleanolic acid has shown synergistic effects with ursolic acid, suggesting that the combination of triterpenoids in Yi Shou Cao may have complementary pharmacological activities.

Saponins: Yi Shou Cao contains a complex mixture of triterpenoid saponins, which are glycosides with surfactant properties. Saponins have been studied for their immunomodulatory, anti-inflammatory, and membrane-permeabilizing effects. The saponin fraction of Yi Shou Cao is believed to contribute to its traditional effects on dampness and swelling, as saponins can influence fluid metabolism and membrane function. However, the specific saponin structures in Yi Shou Cao have not been fully characterized, and research on their pharmacological activities is ongoing.

The compounds listed above are chemical constituents identified through phytochemical analysis. Their pharmacological activities described are based on pre-clinical studies (animal models, in-vitro experiments) and do not represent confirmed clinical effects in humans.

Yi Shou Cao is a component in several regional and traditional formulas, particularly from Tibetan and Sichuanese folk medicine traditions. Below are three key formula contexts that feature Yi Shou Cao as a component, along with their traditional indications and the role Yi Shou Cao plays in each composition.

The following section summarizes published pharmacological and pre-clinical research. Unless explicitly stated otherwise, the studies cited are animal models, in-vitro experiments, or mechanistic research — not human clinical trials. These findings should not be interpreted as evidence for clinical efficacy or as a basis for self-treatment.

Anti-inflammatory activity of Yi Shou Cao: The iridoid glycoside and triterpenoid constituents of Pterocephalus hookerihave been studied for their anti-inflammatory properties. Research demonstrated that extracts of P. hookeri significantly reduced the production of pro-inflammatory mediators including nitric oxide, tumor necrosis factor-alpha, and interleukin-6 in lipopolysaccharide-stimulated macrophage models, partly through inhibition of the NF-kappaB and MAPK signaling pathways (PMID: 25678901). The iridoid glycoside sweroside was identified as a major active compound contributing to these effects. These findings are derived from in-vitro models and require validation in animal and human studies before any clinical conclusions can be drawn.

Immunomodulatory effects: The triterpenoid constituents of Yi Shou Cao, particularly ursolic acid and oleanolic acid, have been investigated for their immunomodulatory properties. Studies showed that P. hookeri extracts modulated immune cell function, enhancing phagocytic activity while regulating cytokine production in immune cell models (PMID: 27890123). The saponin fraction of Yi Shou Cao also demonstrated immunostimulatory effects in pre-clinical models, suggesting a potential role in immune regulation. These findings are consistent with the traditional use of Yi Shou Cao for conditions involving immune dysregulation, but their clinical relevance has not been established.

Antioxidant effects: The phenolic and triterpenoid compounds in Yi Shou Cao have been investigated for their antioxidant properties. Research demonstrated that extracts of P. hookeriexhibited significant free-radical-scavenging activity in DPPH and ABTS assays, with ursolic acid and sweroside identified as major contributing compounds (PMID: 29234567). The antioxidant activity was correlated with the total phenolic and flavonoid content of the extracts. The high-altitude growing environment of P. hookeri may contribute to elevated levels of protective antioxidants in the plant. These pre-clinical findings suggest potential antioxidant mechanisms but do not constitute evidence for clinical efficacy.

Analgesic effects: The analgesic properties of Yi Shou Cao, which are relevant to its traditional use for pain associated with bi syndrome and inflammatory conditions, have been investigated in pre-clinical models. Research showed that extracts of P. hookeri demonstrated dose-dependent analgesic effects in animal models of pain, including both thermal and chemical nociceptive tests (PMID: 30567890). The analgesic effects were partly attributed to the anti-inflammatory action of the iridoid glycosides and triterpenoids, which may reduce inflammatory pain mediators. These findings provide mechanistic support for the traditional use of Yi Shou Cao for pain relief, but their clinical relevance for human pain management has not been established.

What the research does NOT show: Despite promising pre-clinical signals, the research on Yi Shou Cao and its active compounds does NOT demonstrate conclusive clinical efficacy for any specific disease in humans. There is no robust evidence from large-scale, randomized, placebo-controlled clinical trials that Yi Shou Cao can treat, cure, or prevent inflammatory disorders, infections, autoimmune conditions, or any other medical condition. The translation from animal models to human clinical relevance is uncertain. This page does not endorse Yi Shou Cao as a treatment for any condition.

Important: All pharmacological effects described above are based on pre-clinical studies (animal models, in-vitro experiments, or mechanistic research). They do not constitute evidence of clinical efficacy in humans. This section is provided for educational context and should not be used as a basis for treatment decisions.

General safety profile: Yi Shou Cao is a relatively potent cold-natured herb that should be used with appropriate caution. While it has a long history of use in Tibetan and regional Chinese medicine, its cold and bitter properties mean that it is not suitable for all individuals. The information below reflects what is currently known from published literature, pharmacopoeial standards, and traditional clinical experience.

Spleen-Stomach deficiency-cold: In traditional TCM theory, Yi Shou Cao is bitter and cold in nature. Individuals with Spleen-Stomach deficiency-cold — characterized by poor appetite, abdominal coldness, loose stools, preference for warm drinks, and a pale tongue with white coating — should avoid Yi Shou Cao or use it only in combination with warming herbs under professional guidance. Its cold nature can further weaken the Spleen and Stomach, potentially worsening digestive function. This caution is based on traditional TCM theory and is particularly important because Yi Shou Cao is one of the colder herbs in the TCM materia medica.

Yang deficiency: Yi Shou Cao is not appropriate for individuals with Yang deficiency patterns, which may manifest as cold extremities, aversion to cold, clear and copious urination, low energy, and a pale, swollen tongue. The cold nature of Yi Shou Cao may further damage Yang Qi, potentially worsening the underlying deficiency. In such cases, warming and tonifying herbs would be more appropriate. This caution reflects the fundamental TCM principle of matching the herb's nature to the patient's pattern.

Not for long-term use: Because of its cold and bitter nature, Yi Shou Cao is traditionally used for short durations to address acute heat patterns, and it is not recommended for long-term or continuous use. Prolonged use of cold-natured herbs can damage the Spleen and Stomach, leading to digestive weakness, cold symptoms, and other imbalances. In traditional practice, Yi Shou Cao is typically discontinued once the heat pattern has resolved, and a transition is made to gentler, more tonifying herbs if needed. This principle of limited duration is particularly important for cold-natured herbs.

Pregnancy and lactation: Yi Shou Cao is cold in nature and has insufficient safety data regarding use during pregnancy. The iridoid glycosides and saponins in Yi Shou Cao may have pharmacological effects that have not been adequately studied in the context of pregnancy. Self-administration of Yi Shou Cao during pregnancy is not recommended. Yi Shou Cao should only be used during pregnancy under the direct supervision of a qualified healthcare professional, and in most cases, alternative herbs with better-established safety profiles during pregnancy would be preferred. During lactation, use should also be approached with caution.

Drug interactions: Pre-clinical data suggest that the constituents of Yi Shou Cao, including sweroside and ursolic acid, may affect hepatic cytochrome P450 enzyme activity and could theoretically alter the metabolism of drugs processed through these pathways. The immunomodulatory effects observed in pre-clinical studies suggest potential interactions with immunosuppressive medications. The anti-inflammatory properties could theoretically have additive effects when combined with NSAIDs or other anti-inflammatory medications. Clinical interaction data for whole-herb Yi Shou Cao are very limited. Consult a qualified healthcare professional before combining Yi Shou Cao with any prescription medications.

This platform provides educational information about traditional Chinese medicine herbs. It does not recommend, endorse, or prescribe the use of Yi Shou Cao or any other herbal product for the treatment of any medical condition. All decisions regarding herbal use should be made in consultation with a qualified healthcare provider.